Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alder Biopharma (ALDR)

Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alder Biopharma 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 USA

www.alderbio.com P: 425-205-2900

Description:

Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.

Key Statistics

Overview:

Market Capitalization, $K 1,582,842
Shares Outstanding, K 83,837
Annual Sales, $ 0 K
Annual Net Income, $ -296,430 K
60-Month Beta 2.64
% of Insider Shareholders 15.40%
Float, K 70,926
% Float 84.60%

Growth:

1-Year Return 49.96%
3-Year Return -23.87%
5-Year Return 5.42%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -418.09%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/04/19
Earnings Per Share ttm -3.54
EPS Growth vs. Prev Qtr 55.83%
EPS Growth vs. Prev Year 30.77%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ALDR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -226.13%
Return-on-Assets % -66.86%
Profit Margin % 0.00%
Debt/Equity 1.66
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 14.29
Book Value/Share 0.00
Interest Coverage -16.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar